Biotech Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting May 22, 2026
Biotech BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia May 21, 2026
Biotech FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain May 19, 2026
Biotech BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update May 17, 2026
Biotech Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success May 16, 2026
Biotech Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease May 14, 2026